Free Trial
NASDAQ:HSIC

Henry Schein (HSIC) Stock Price, News & Analysis

Henry Schein logo
$74.53 +0.37 (+0.50%)
Closing price 04:00 PM Eastern
Extended Trading
$74.53 0.00 (0.00%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Henry Schein Stock (NASDAQ:HSIC)

Key Stats

Today's Range
$73.77
$75.76
50-Day Range
$64.46
$74.67
52-Week Range
$60.56
$82.49
Volume
1.07 million shs
Average Volume
1.72 million shs
Market Capitalization
$9.07 billion
P/E Ratio
23.29
Dividend Yield
N/A
Price Target
$79.70
Consensus Rating
Moderate Buy

Company Overview

Henry Schein Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

HSIC MarketRank™: 

Henry Schein scored higher than 60% of companies evaluated by MarketBeat, and ranked 397th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Henry Schein has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on 5 buy ratings, 5 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Henry Schein has only been the subject of 4 research reports in the past 90 days.

  • Read more about Henry Schein's stock forecast and price target.
  • Earnings Growth

    Earnings for Henry Schein are expected to grow by 5.91% in the coming year, from $4.74 to $5.02 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Henry Schein is 23.33, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.67.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Henry Schein is 23.33, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.18.

  • Price to Earnings Growth Ratio

    Henry Schein has a PEG Ratio of 2.38. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Henry Schein has a P/B Ratio of 2.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Henry Schein's valuation and earnings.
  • Percentage of Shares Shorted

    7.64% of the float of Henry Schein has been sold short.
  • Short Interest Ratio / Days to Cover

    Henry Schein has a short interest ratio ("days to cover") of 5.2.
  • Change versus previous month

    Short interest in Henry Schein has recently increased by 1.52%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Henry Schein does not currently pay a dividend.

  • Dividend Growth

    Henry Schein does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.64% of the float of Henry Schein has been sold short.
  • Short Interest Ratio / Days to Cover

    Henry Schein has a short interest ratio ("days to cover") of 5.2.
  • Change versus previous month

    Short interest in Henry Schein has recently increased by 1.52%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Henry Schein has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Henry Schein this week, compared to 12 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added Henry Schein to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Henry Schein insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.08% of the stock of Henry Schein is held by insiders.

  • Percentage Held by Institutions

    96.62% of the stock of Henry Schein is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Henry Schein's insider trading history.
Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Stock News Headlines

Henry Schein (HSIC) versus Its Peers Head-To-Head Survey
Why Volatility Keeps Coming Back — And How I Trade It
Volatility isn’t the enemy — it’s the opportunity. While most traders panic during market swings, Jeff Clark uses a three-step method to target quick wins from VIX spikes and sudden price moves. It works in any market direction… and he’s showing how it works in a free video, available now.
Head-To-Head Contrast: Henry Schein (HSIC) versus Its Rivals
Head-To-Head Comparison: Henry Schein (HSIC) & Its Rivals
See More Headlines

HSIC Stock Analysis - Frequently Asked Questions

Henry Schein's stock was trading at $69.20 at the start of the year. Since then, HSIC stock has increased by 7.8% and is now trading at $74.5710.

Henry Schein, Inc. (NASDAQ:HSIC) issued its quarterly earnings data on Monday, May, 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein's quarterly revenue was down .1% compared to the same quarter last year.
Read the conference call transcript
.

Henry Schein shares split before market open on Friday, September 15th 2017.The 2-1 split was announced on Wednesday, August 16th 2017. The newly created shares were distributed to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

The following companies are subsidiaries of Henry Schein: Prism Medical Products LLC, Elite Computer Italia, Southern Anesthesia & Surgical, Marrodent, Dental Cremer, RxWorks, Dental Trey, and others.

Henry Schein's top institutional shareholders include Swedbank AB (0.95%), Wealth Enhancement Advisory Services LLC (0.05%), Baker Ellis Asset Management LLC (0.04%) and Czech National Bank (0.02%). Insiders that own company stock include James P Breslawski, Stanley M Bergman, Michael S Ettinger, Lorelei Mcglynn, Mark E Mlotek, David B Brous Jr, Bradford C Connett, Philip A Laskawy and Kurt P Kuehn.
View institutional ownership trends
.

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Henry Schein investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR), AU Optronics (AUOTY) and The RMR Group (RMR).

Company Calendar

Last Earnings
5/05/2025
Today
7/10/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Distributors
Current Symbol
NASDAQ:HSIC
CIK
1000228
Employees
25,000
Year Founded
1932

Price Target and Rating

High Price Target
$86.00
Low Price Target
$75.00
Potential Upside/Downside
+5.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.64
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.20
Trailing P/E Ratio
23.56
Forward P/E Ratio
15.88
P/E Growth
2.38
Net Income
$390 million
Net Margins
3.21%
Pretax Margin
4.19%
Return on Equity
14.87%
Return on Assets
5.82%

Debt

Debt-to-Equity Ratio
0.50
Current Ratio
1.38
Quick Ratio
0.75

Sales & Book Value

Annual Sales
$12.67 billion
Price / Sales
0.72
Cash Flow
$7.46 per share
Price / Cash Flow
10.09
Book Value
$32.33 per share
Price / Book
2.33

Miscellaneous

Outstanding Shares
121,720,000
Free Float
120,405,000
Market Cap
$9.16 billion
Optionable
Optionable
Beta
0.87

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:HSIC) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners